Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Assets Average (2022 - 2026)

Canton Strategic Holdings' (CNTN) quarterly Assets Average came in at $551.9 million in Q1 2026, up 20405.63% YoY from N/an in Q1 2025, and up 109.51% on a QoQ basis from $263.4 million in Q4 2025.

Analysis

Canton Strategic Holdings (CNTN) Assets Average (2022 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 5 years of Assets Average data on file, last reported at $551.9 million in Q1 2026.

  • Quarterly Assets Average rose 20405.63% year-over-year to $551.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $551.9 million (up 20405.63% YoY) and the FY2025 annual result came in at $261.4 million, up 3464.68% from the prior year.
  • Assets Average grew to $551.9 million in Q1 2026, from $263.4 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $551.9 million in Q1 2026 to a low of $2.1 million in Q2 2025.
  • A 5-year average of $53.5 million and a median of $6.8 million in 2024 frame the typical range for Assets Average.
  • Annual changes were most pronounced in 2025 — Assets Average plunged 75.55% — and 2026, when it surged 20405.63%.
  • Tracing CNTN's Assets Average over 5 years: stood at $7.4 million in 2022, then declined by 4.04% to $7.1 million in 2023, then sank by 36.42% to $4.5 million in 2024, then soared by 5771.54% to $263.4 million in 2025, then surged by 109.51% to $551.9 million in 2026.
  • The last three Assets Average figures came in at $551.9 million (Q1 2026), $263.4 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.22 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 3.29 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.86 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 5.34 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.82 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 2.09 Bn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn - 574.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 574.61 Mn
Mar 31, 2026 551.90 Mn
Dec 31, 2025 263.42 Mn
Sep 30, 2025 5.11 Mn
Jun 30, 2025 2.10 Mn
Mar 31, 2025 2.69 Mn
Dec 31, 2024 4.49 Mn
Sep 30, 2024 6.75 Mn
Jun 30, 2024 8.57 Mn
Mar 31, 2024 9.92 Mn
Dec 31, 2023 7.06 Mn
Sep 30, 2023 3.88 Mn
Jun 30, 2023 4.66 Mn
Mar 31, 2023 5.71 Mn
Dec 31, 2022 7.35 Mn
Sep 30, 2022 9.13 Mn
Jun 30, 2022 11.17 Mn
Mar 31, 2022 6.36 Mn